£50,000 boost for stroke prevention device
Rapid Rhythm Ltd, a spin-out company jointly owned by TRUSTECH Smart Healthcare Ventures Ltd (SHV) and Central Manchester University...
Read moreThe i4i Challenge Awards is a new i4i funding stream that aims to bridge the gap between the innovation and development of new medical technology and its adoption into clinical pathways.
Despite clinical evidence for its use, the cost and risk of implementing a new device into clinical pathways can make it difficult to get the product adopted into clinical practice. The NIHR has allocated £15 million over the next three years to the i4i Challenge Awards to help overcome these issues by identifying and supporting the application of emerging platform technologies which hold the potential to have a disruptive impact on clinical pathways.
The first challenge that the i4i Challenge Awards will address is cardiovascular disease – the leading cause of death in England and worldwide.
The first i4i Challenge Awards call for proposals will open on 27 February 2012.
For full details, please visit: http://www.ccf.nihr.ac.uk/i4i/Pages/i4iChallengeawards.aspx
Rapid Rhythm Ltd, a spin-out company jointly owned by TRUSTECH Smart Healthcare Ventures Ltd (SHV) and Central Manchester University...
Read moreThe NHS Innovation Challenge Prizes have been created to recognise and reward ideas that tackle some of the most...
Read moreThe £180 million Biomedical Catalyst, announced by David Cameron in December 2011, will see the Medical Research Council and...
Read moreRegister to receive newsletters and information about new programmes and events.
Add a Comment